ZHONGZHIPHARM

3737
0.6702.29% ( +0.015 )
Delay Closed: Nov 16, 16:08:00

Valuation

Current ValuationThe current P/E ratio is 28.52, within the reasonable range, cheaper than 67.43% of the time in the past 1 years, and the industry ranks 25/53, the industry Median 6.94.

28.52xP/E
Stock priceHK$0.67Earnings per shareHK$0.02

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.94x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.94x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
03692HKHANSOH PHARMA
26.74x23.06%HK$205.57B
03933HKUNITED LAB
23.42x55.30%HK$14.54B
00460HKSIHUAN PHARM
20.33x322.94%HK$7.06B
09989HKHEPALINK
26.68x18.84%HK$5.90B
06996HKANTENGENE-B
28.74x246.19%HK$1.77B
03737HKZHONGZHIPHARM
28.52x--HK$578.61M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.